Medirio SA

Gegründet: Dezember 2013

Instrument to deliver insulin discretely as substitute for insulin pens and syringes

Medirio is developing a new drug delivery system targeting the insulin pens market: a new unique product allowing diabetic patients to manage their insulin injections in an easier and discreet way . Each insulin dose will be administrated with no effort. Our medical device is indeed designed to significantly improve both efficiency and therapy control, together with a fresh new user experience which eases and simplifies the medication-related action plan; bringing innovation into the insulin pen market and answering insulin pen users and doctors' unmet needs with no increase in therapy cost.

Milestones / News

Funding Activity

We are finalizing the last patch prototype in order to start industrialization